Projects

A prospective active controlled, randomised, double blind, multicentre phase III study to compare the safety and efficacy of Biosimilar Denosumab of Enzene Biosciences Ltd vs Innovator Denosumab in the treatment of Postmenopausal osteoporosis

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2018 - 2018

Project Lead

Dr Joe Joseph Cherian

Authors

Dr. Joe Joseph Cherian

Project Status

completed

Project Type

Phase III